JVMRX | TCVAX | JVMRX / TCVAX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 13 years | 15 years | - |
Gain YTD | 2.079 | 0.715 | 291% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000000 | 2500 | 40,000% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 22.5B | 576M | 3,906% |
Annual Yield % from dividends | 0.93 | 0.84 | 111% |
Returns for 1 year | -1.71 | 2.52 | -68% |
Returns for 3 years | 4.02 | -0.46 | -878% |
Returns for 5 years | 25.72 | 17.61 | 146% |
Returns for 10 years | 38.31 | 36.55 | 105% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
TQMVX | 17.90 | -0.22 | -1.21% |
T. Rowe Price Integrated US LCV Eq | |||
IPLIX | 30.66 | -0.54 | -1.73% |
Voya Index Plus LargeCap Port I | |||
FSCWX | 32.97 | -0.65 | -1.93% |
Nuveen Small Cap Value R6 | |||
NGDLX | 29.73 | -0.59 | -1.95% |
Neuberger Berman Large Cap Growth Inst | |||
JGVVX | 43.04 | -1.13 | -2.56% |
JPMorgan Growth Advantage R6 |